Clinical Experience with Linezolid for the Treatment ofNocardiaInfection
Top Cited Papers
Open Access
- 1 February 2003
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (3) , 313-318
- https://doi.org/10.1086/345907
Abstract
Linezolid is an oxazolidinone that has activity against most gram-positive bacteria, including in vitro activity against all Nocardia species and strKeywords
This publication has 26 references indexed in Scilit:
- NocardiaInfection in Chronic Granulomatous DiseaseClinical Infectious Diseases, 2002
- Oxazolidinone antibioticsThe Lancet, 2001
- In Vitro Activity of PNU-100766 (Linezolid), a New Oxazolidinone Antimicrobial, against Nocardia brasiliensisAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Activities of Linezolid against Multiple Nocardia SpeciesAntimicrobial Agents and Chemotherapy, 2001
- Antimicrobial susceptibility profile of soil isolates of Nocardia asteroides from KuwaitClinical Microbiology & Infection, 2000
- NocardiosisClinical Infectious Diseases, 1996
- Nocardia species: host-parasite relationshipsClinical Microbiology Reviews, 1994
- Drug-Resistant Nocardia asteroides Infection in a Patient With Acquired Immunodeficiency SyndromeSouthern Medical Journal, 1991
- Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1984
- Sulfonamides in Experimental Nocardiosis, Histoplasmosis, and South American BlastomycosisChemotherapy, 1968